Evidence map›Paper›PMID 26886938›Full record

ArticlePloS one2016

Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVΔnef Vaccination.

Natalia Guerra-Pérez, Meropi Aravantinou, Filippo Veglia, Diana Goode, Rosaline Truong, Nina Derby, James Blanchard, Brooke Grasperge, Agegnehu Gettie, Melissa Robbiani and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Blocking αScience translational medicine · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.Journal of acquired immune deficiency syndromes (1999) · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Natalia Guerra-PérezCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Meropi AravantinouCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Filippo VegliaCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Diana GoodeCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Rosaline TruongCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Nina DerbyCenter for Biomedical Research, Population Council, New York, New York, United States of America.
James BlanchardTulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Brooke GraspergeTulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Agegnehu GettieAaron Diamond AIDS Research Center, Rockefeller University, New York, New York, United States of America.
Melissa RobbianiCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Elena MartinelliCenter for Biomedical Research, Population Council, New York, New York, United States of America.
Population Council · USTulane University · USAaron Diamond AIDS Research Center · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
The Mucosal Dendritic Cell T Milieu and SIV SpreadR01AI040877 · NIAID · ROCKEFELLER UNIVERSITY · PI DERBY, NINA R. · 1997 to 2016
$6.9M
Modulating mucosal DCs and T cells to limit SIV spreadR37AI040877 · NIAID · POPULATION COUNCIL · PI ROBBIANI, MELISSA J · 2007 to 2013
$6.4M
Research Training in Experimental Medicine and PathologyT32OD011124 · OD · TULANE UNIVERSITY OF LOUISIANA · PI BLAIR, ROBERT, RAPPAPORT, JAY · 2012 to 2019
$2.7M
Anti-angiogenic actions of taxotereR01CA098456 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SCHWARTZ, EDWARD L · 2003 to 2007
$1.3M
NCI NIH HHS R01 CA098456NIAID NIH HHS R01 AI040877NIAID NIH HHS R01 AI098456-04NIAID NIH HHS R37 AI040877NIAID NIH HHS R37 AI040877-18NIAID NIH HHS U24 AI126683NIH HHS OD011104NIH HHS P51 OD011104NIH HHS T32 OD011124
6 · The paper itself

Abstract

Prevalent HSV-2 infection increases the risk of HIV acquisition both in men and women even in asymptomatic subjects. Understanding the impact of HSV-2 on the mucosal microenvironment may help to identify determinants of susceptibility to HIV. Vaginal HSV-2 infection increases the frequency of cells highly susceptible to HIV in the vaginal tissue of women and macaques and this correlates with increased susceptibility to vaginal SHIV infection in macaques. However, the effect of rectal HSV-2 infection on HIV acquisition remains understudied. We developed a model of rectal HSV-2 infection in macaques in combination with rectal SIVmac239Δnef (SIVΔnef) vaccination and our results suggest that rectal HSV-2 infection may increase the susceptibility of macaques to rectal SIVmac239 wild-type (wt) infection even in SIVΔnef-infected animals. Rectal SIVΔnef infection/vaccination protected 7 out of 7 SIVΔnef-infected macaques from SIVmac239wt rectal infection (vs 12 out of 16 SIVΔnef-negative macaques), while 1 out of 3 animals co-infected with SIVΔnef and HSV-2 acquired SIVmac239wt infection. HSV-2/SIVmac239wt co-infected animals had increased concentrations of inflammatory factors in their plasma and rectal fluids and a tendency toward higher acute SIVmac239wt plasma viral load. However, they had higher blood CD4 counts and reduced depletion of CCR5+ CD4+ T cells compared to SIVmac239wt-only infected animals. Thus, rectal HSV-2 infection generates a pro-inflammatory environment that may increase susceptibility to rectal SIV infection and may impact immunological and virological parameters during acute SIV infection. Studies with larger number of animals are needed to confirm these findings.

Indexed as

VaccinationAnimalsCD4 Lymphocyte CountCoinfectionCytokinesGene Products, nefHerpesvirus 2, HumanHumansInflammationLymph NodesMacaca mulattaMalePhenotypeRectumSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusCytokinesGene Products, nef

Identifiers

PMID26886938
PMCPMC4757571
OpenAlexW2278603204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.